When cardiologists send their high-risk patients home, they may be protected with a host of tools, including implantable cardiac devices and pacemakers and strict regimens of medications. While the tools and regimens are powerful, cardiologists know that they are still limited when it comes to preventing adverse events. Without constant check-ups, serious coronary issues can occur.
CardioDynamics recently received market clearance from the FDA for its BioZ Impedance Cardiography (ICG) clinical ...
February 5, 2008 - Premera Blue Cross has revised its Corporate Medical Policy to make Microvolt T-Wave Alternans ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
The latest version of GE’s MUSE 7.0 system reportedly incorporates enhancements in information technology, ECG management processes and clinical report editing in an all-digital environment for paperless workflow.
February 5, 2008 - The Medical Imaging & Technology Alliance (MITA), a division of NEMA, said today that the budget ...
February 4, 2008 - InSite One Inc.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
February 4, 2008 – Fluke Biomedical unveiled today new defibrillator and pacemaker analyzer technologies, the Impulse 6000D Defibrillator Analyzer and the Impulse 7000DP Defibrillator/Pacer Analyzer, which are designed to be rugged, portable test instrumentation for biomedical technical professionals to ensure proper operation and ultimate performance of critical life-support cardiac resuscitati
February 4, 2008 - The Centers for Medicare & Medicaid Services (CMS) announced that after completing a review of its 1986 national non-coverage policy for artificial hearts, its preliminary decision is to provide reimbursement for patients who receive the CardioWest temporary Total Artificial Heart (TAH-t) as part of FDA studies that meet CMS specifications.
Fluke Biomedical's product line of defibrillator and pacemaker analyzer technologies includes the Impulse 6000D ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
February 1, 2008 - NightHawk Radiology will be a radiology provider for the High-Risk Plaque Initiative (HRP Initiative), a joint research effort to advance the understanding and management of high-risk plaque, which is believed to be the primary underlying cause of heart attacks and strokes.
February 1, 2008 - Medical Ventures Corp. signed an agreement to acquire two vascular product development companies ...
February 1, 2008 - Stentys' bifurcated stent was successfully implanted recently into a 49-year-old male patient at the ThoraxCenter, Erasmus Medical Center, Rotterdam, the Netherlands, marking the sixth successful implantation of the Stentys bifurcated stent platform.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
February 1, 2008 - Medtronic Inc. has received approval from the FDA for the Endeavor Zotarolimus-Eluting Coronary Stent ...
January 31, 2008 - Stentys' bifurcated stent was successfully implanted recently into a 49-year-old male patient at the ...
February 1, 2008 - Abbott has received reimbursement approval in France for its XIENCE V Everolimus Eluting Coronary ...